NKGen Biotech (NKGN) has released an update to notify the public and investors about its officers.
Alana McNulty has stepped down from her roles on NKGen Biotech’s Board and its key committees, effective immediately. Her departure, which was not due to any conflict, leaves the Board and its Committees with fewer members. The Board plans to fill the vacancy within six months, while appreciating McNulty’s significant contributions to the company.
For further insights into NKGN corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.
